Center for Translational Research acquires Zelmic AB

Center for Translational Research acquires Zelmic AB

Center for Translational Research AB (CTR) expands by acquiring Zelmic AB, the GMP-approved Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), specialized in development of topical and transdermal pharmaceutical...
Center for Translational Research launches CTC Netherlands

Center for Translational Research launches CTC Netherlands

29 February, 2024 Center for Translational Research expands its portfolio of life science service companies through the establishment of CTC Netherlands BV – the CTR group’s first company outside of Sweden.  Sweden-based Center for Translational Research (CTR) has...
CTR Center for Translational Research AB acquires A+ Science AB

CTR Center for Translational Research AB acquires A+ Science AB

CTR Center for Translational Research AB (CTR) has recently completed a strategic acquisition of A+ Science AB. As part of the agreement, all operations within A+ will be integrated into CTR’s wholly-owned subsidiary, CTC Clinical Trial Consultants AB (CTC). The...
CTR establishes QAlliance – Quality assurance in Life Science

CTR establishes QAlliance – Quality assurance in Life Science

CTR starts a new subsidiary – QAlliance AB – to support the Life Science industry with expertise and operational support within QA, quality assurance. The business will be led by Raf Lemmens, who has been appointed CEO of the company. In recent years, Raf...